Thought this was an interesting find in the local paper.
HPV is not on my list. Part of it is the adequate long term data and the other is frankly the reported reactions. However, I do think it highlights the issue of whether or not the full number of doses are required for all vaccines.
So researchers analysed blood samples from a group of 78 who got one dose, compared to groups of 120 to 192 that received two or three doses as planned.
They found that all the women in all three groups had antibodies against virulent strains of HPV, known as 16 and 18.
The levels of antibodies also appeared stable over time, even though they were slightly lower in the single dose group, suggesting "these are lasting responses," said the study.
|28 members and 14,567 guests|
|agentofchaos , AmandaRemo , Bow , celiguetapatri , CricketVS , darionjefta , Deborah , Dovenoir , easydoesit , emmy526 , esg , jamesmorrow , Katherine73 , kathymuggle , Kelleybug , lmbjer , Michele123 , Mirzam , moominmamma , mumto1 , PDTV , pokeyac , rightkindofme , rubelin , samaxtics , sren , zoeyzoo|
|Most users ever online was 449,755, 06-25-2014 at 12:21 PM.|